In vivo metabolism of the cardiovascular toxin, allylamine

Paul J. Boor, Radhika Sanduja, Thomas J. Nelson, G. A.S. Ansari

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Previous evidence from this laboratory demonstrated that allylamine, a known cardiovascular toxin, is metabolized in vitro to acrolein, which has been hypothesized to act as a distal toxin. In this study, 3-hydroxypropylmercapturic acid was isolated and identified by MS, NMR, and 2D-NMR spectroscopy as the sole urinary metabolite of allylamine metabolism in vivo. Parallel experiments showed reduced glutathione (GSH) depletion in several organs (most marked in aorta, blood, and lung), which is consistent with GSH conjugation of the proposed acrolein intermediate. These findings indicate that allylamine was metabolized in vivo to a highly reactive aldehyde which was converted to a mercapturic acid through a GSH conjugation pathway; the exact mechanisms of cellular damage remain unclear.

Original languageEnglish (US)
Pages (from-to)4347-4353
Number of pages7
JournalBiochemical Pharmacology
Issue number24
StatePublished - Dec 15 1987
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology


Dive into the research topics of 'In vivo metabolism of the cardiovascular toxin, allylamine'. Together they form a unique fingerprint.

Cite this